)
Rhythm Pharmaceuticals (RYTM) investor relations material
Rhythm Pharmaceuticals Proxy filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Shareholder rights and capital structure
As of May 22, 2026, there were 68,593,574 shares of Common Stock and 115,000 shares of Convertible Preferred Stock outstanding.
Major shareholders include RA Capital Management (9.7%), Baker Bros. Advisors (8.2%), BlackRock (6.4%), PRIMECAP Management (5.1%), and Perceptive Advisors.
Convertible Preferred Stock has conversion limits to prevent holders from exceeding specified ownership thresholds (4.99% for Baker Bros., 9.99% for Perceptive Advisors).
Voting and dispositive powers for institutional holders are often delegated to investment managers or advisers.
Board of directors and corporate governance
Directors and executive officers as a group (13 persons) beneficially own 5.9% of Common Stock.
Individual director and executive officer ownership includes both direct holdings and options/restricted stock units vesting within 60 days.
Related party transactions
Investment managers and advisers, such as RA Capital, Baker Bros., and Perceptive Advisors, may be deemed beneficial owners due to delegated voting and investment authority.
- IMCIVREE delivers significant BMI and hunger reductions in rare obesity, driving global growth.RYTM
Corporate presentation29 May 2026 - IMCIVREE drives global growth with robust efficacy in rare obesity disorders and a strong pipeline.RYTM
Corporate presentation14 May 2026 - Strong HO launch, global reach, and next-gen therapies drive growth in rare obesity markets.RYTM
Bank of America Global Healthcare Conference 202613 May 2026 - Q1 2026 revenue rose 59% to $60.1M, with global IMCIVREE expansion and higher operating loss.RYTM
Q1 20265 May 2026 - Virtual annual meeting to vote on directors, auditor, and executive pay, with online access options.RYTM
Proxy filing5 May 2026 - Proxy covers director elections, auditor ratification, Say-on-Pay, and robust ESG and compensation practices.RYTM
Proxy filing29 Apr 2026 - IMCIVREE launches in HO, with global expansion and pivotal PWS data expected mid-year.RYTM
25th Annual Needham Virtual Healthcare Conference16 Apr 2026 - FDA approves IMCIVREE as the first therapy for acquired hypothalamic obesity after strong Phase 3 results.RYTM
Study update20 Mar 2026 - Post hoc analyses showed significant BMI reductions in POMC/PCSK1 and SRC1 cohorts.RYTM
Study result17 Mar 2026
Next Rhythm Pharmaceuticals earnings date
Next Rhythm Pharmaceuticals earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
Frequently asked questions
Explore our global coverage